Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Long OT Holiday read

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Feb 15, 2021 10:51pm

162 Views

Post# 32570656

RE:Long OT Holiday read

Dr. William Grace, Oncologist and Hematologist, says in his opinion Vitamin D3 is the biggest single factor in fighting the onset of Covid-19 yet the CDC and NIH under the control of Dr. Fauci never provide any such information as they keep preaching on mask wearing and physical distancing at every opportunity. As always -- makes one wonder!

<< Previous

Bullboard Posts

Next >>

BMO launches enhanced platform with tools for options trading